The Veterinary Teaching Hospital, University of Sydney, Sydney, New South Wales, Australia
The Veterinary Teaching Hospital, University of Sydney, Sydney, New South Wales, Australia.
Vet Rec. 2020 Sep 5;187(5):190. doi: 10.1136/vr.105360. Epub 2019 Nov 5.
The aim of the study was to discover the extent of use of essential fatty acids (EFAs) in veterinary practice, conditions used in, preparation of EFA supplement used and rationale for their use and to investigate the awareness of the oxidation of some commercial fish oil supplement preparations.
A web-based questionnaire was distributed via email to a dermatology list server and posted to veterinary Facebook groups with questions relating to the use of EFAs, supplement choice, conditions used in, the level of importance of various factors regarding their use and awareness of their oxidation.
There were 309 responses from 32 countries. EFA supplements were used by 92.2 per cent of respondents. The most commonly used preparation of EFA supplementation was veterinary oral supplements (75.1 per cent), followed by veterinary diets (14.4 per cent), shop bought fish oil supplements (7.7 per cent), enhancing the diet with oily fish (2.5 per cent) and finally using a commercial pet food (0.3 per cent). Only 46.3 per cent of respondents who used them were aware of the oxidation of EFAs. Veterinary oral supplements were perceived to be the best preserved, followed by veterinary diets and lastly commercial fish oil supplements.
A large number of respondents advised the use of EFAs for veterinary dermatological conditions but less than 50 per cent were aware of the potential for EFAs to oxidise.
本研究旨在探讨兽医实践中必需脂肪酸（EFAs）的使用情况、使用条件、EFA 补充剂的制备以及使用的基本原理，并调查一些商业鱼油补充剂制剂氧化的认识情况。
通过电子邮件向皮肤病学列表服务器分发基于网络的问卷，并发布到兽医 Facebook 群组，问题涉及 EFA 的使用、补充剂选择、使用条件、使用各种因素的重要性以及对其氧化的认识。
来自 32 个国家的 309 名受访者做出了回应。92.2%的受访者使用 EFA 补充剂。最常用的 EFA 补充剂制备是兽医口服补充剂（75.1%），其次是兽医饮食（14.4%）、商店购买的鱼油补充剂（7.7%）、用油性鱼增强饮食（2.5%），最后是使用商业宠物食品（0.3%）。只有 46.3%使用 EFA 的受访者意识到 EFA 的氧化。兽医口服补充剂被认为是保存最好的，其次是兽医饮食，最后是商业鱼油补充剂。
大量受访者建议在兽医皮肤科疾病中使用 EFAs，但不到 50%的受访者意识到 EFAs 可能会氧化。
